An experimental Ebola vaccine tested on humans in Europe and Africa sparks the production of the antibodies needed to neutralise the deadly virus, a Geneva hospital said Wednesday. There is no licensed treatment or vaccine for Ebola, and the World Health Organization last year endorsed rushing potential ones through trials in a bid to stem the epidemic still simmering in west Africa. Initial clinical trials of the VSV-ZEBOV candidate vaccine, manufactured by the Public Health Agency of Canada and developed by Merck, show that it "triggers the production of antibodies capable of neutralising the Ebola virus," the Geneva University Hospitals (HUG) said in a statement.
via Health News Headlines - Yahoo News http://ift.tt/1xA9SnT
No comments:
Post a Comment